|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,617 GBX | +1.05% |
|
+0.03% | +11.40% |
| 01:18pm | GSK : UBS gives a Buy rating | ZD |
| 09:12am | GSK : JP Morgan remains a Sell rating | ZD |
June 11 (Reuters) - GSK plc:
* STATEMENT: ZANTAC (RANITIDINE) LITIGATION
* DELAWARE SUPERIOR COURT'S RULING INCONSISTENT WITH HOW DAUBERT STANDARD* HAS PREVIOUSLY BEEN APPLIED IN DELAWARE AND FEDERAL COURTS
* APPLICATION HAS BEEN FILED SEEKING RIGHT OF APPEAL TO DELAWARE SUPREME COURT
* GSK, PFIZER, SANOFI, AND BOEHRINGER INGELHEIM ARE ALL PARTIES TO APPLICATION Source text for Eikon: Further company coverage:
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,617 GBX | +1.05% | +0.03% | 82.79B | ||
| 88.67 EUR | +1.14% | -1.36% | 118B | ||
| 26.98 USD | -2.00% | -3.88% | 153B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +11.40% | 82.79B | |
| +51.82% | 797B | |
| +40.70% | 628B | |
| -6.88% | 351B | |
| +16.95% | 323B | |
| +9.49% | 300B | |
| +17.02% | 244B | |
| +0.90% | 223B | |
| +5.30% | 163B | |
| -6.29% | 153B |
GSK PLC 
